BS ISO 11737-3:2023
$215.11
Sterilization of health care products. Microbiological methods – Bacterial endotoxin testing
Published By | Publication Date | Number of Pages |
BSI | 2023 | 72 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 1.1 Inclusions 1.2 Exclusions 2 Normative references 3 Terms and definitions |
15 | 4 General requirements |
16 | 5 Selection of products 5.1 General 5.2 Selection of product units |
17 | 6 Methods for BET 6.1 General |
18 | 6.2 Consideration of an applicable endotoxin limit 6.2.1 Endotoxin limit 6.2.2 Calculation of endotoxin limit for the extract solution 6.2.3 Maximum valid dilution (MVD) |
19 | 6.3 Critical test parameters 6.3.1 Temperature 6.3.2 Time 6.3.3 pH 6.4 Equipment and materials |
20 | 6.5 Reagents 7 Method suitability for BET (BET validation) 7.1 General 7.2 Product and test method suitability 7.2.1 Gel-clot technique |
21 | 7.2.2 Kinetic and end point methods (chromogenic and turbidimetric techniques) |
22 | 7.3 Sample preparation 7.3.1 General 7.3.2 Solid health care products |
23 | 7.3.3 Aqueous health care products 7.3.4 Sample interference 7.4 Reagent and analyst qualification 7.4.1 Gel-clot technique reagent qualification 7.4.2 Kinetic and end point method reagent qualification |
24 | 7.4.3 Analyst qualification 8 Routine testing, monitoring and interpretation of data 8.1 Routine testing 8.1.1 Gel-clot limit test 8.1.2 Gel-clot assay |
25 | 8.1.3 Kinetic and end point methods (chromogenic and turbidimetric) 8.2 Monitoring (test frequency) 8.3 Interpretation of results 8.3.1 General |
26 | 8.3.2 Gel clot methods 8.3.3 Kinetic and end point methods 8.4 Data analysis 8.5 Statistical methods 9 Maintenance of the BET method 9.1 General 9.2 Changes to either the product or manufacturing process, or both |
27 | 9.3 Changes to the BET method 10 Alternatives to batch testing 10.1 General 10.2 Criteria for establishing alternatives to batch testing |
28 | 10.3 Manufacturing process assessment 10.3.1 Quality planning of manufacturing processes 10.3.2 Process design 10.3.3 Process control |
29 | 10.4 Change control 10.5 Maintenance of risk assessment |
30 | Annex A (informative) Guidance on bacterial endotoxin testing (following the subclauses in this document) |
50 | Annex B (informative) History and background on the bacterial endotoxins test (BET) |
54 | Annex C (informative) Guidance on out of specified limits (OSL) and failure investigation |
58 | Annex D (informative) Guidance on in-process monitoring of manufacturing processes or component testing |
61 | Annex E (informative) Guidance on conducting a risk assessment to support alternatives to batch testing |
66 | Annex F (informative) Typical assignment of responsibilities |
68 | Bibliography |